Neurology Neuroimmunology & Neuroinflammation · 2024 · 27 citations · 32 references
Life SciencesNeurologyNeuroscienceAutoimmunityClinical NeuroscienceNeuroimmunologyAutoimmune Disease PathogenesisAutoimmune DiseasesAutoimmune Neurological DisordersEncephalitisAntibody-mediated Neurologic DiseaseAutoimmune Neurological DiseaseDisease Relapse PredictionEncephalitis PrognosisImmune-mediated Encephalitis
BACKGROUND AND OBJECTIVES: Relapses occur in 15%-25% of patients with leucine-rich glioma-inactivated 1 antibody (LGI1-Ab) autoimmune encephalitis and may cause additional disability. In this study, we clinically characterized the relapses and identified factors predicting their occurrence. METHODS: This is a retrospective chart review of patients with LGI1-Ab encephalitis diagnosed at our center between 2005 and 2022. Relapse was defined as worsening of previous or appearance of new symptoms after at least 3 months of clinical stabilization. RESULTS: = 0.036) were significantly associated with an increased risk of relapse. DISCUSSION: Relapses may occur years after the initial encephalitis episode and are usually milder but cause additional disability. Corticosteroid treatment reduces the risk of future relapses, while patients with residual cognitive dysfunction after the initial episode have an increased relapse risk.
32
Sarosh R. Irani, Katarzyna D. Bera, Patrick Waters et al. · Brain · 2010 · 1K citations · Full text
Medicine, Neurology, Neuroscience +11
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
Sarosh R. Irani, Andrew W. Michell, Bethan Lang et al. · Annals of Neurology · 2010 · 910 citations
Medicine, Neurology, Neuroscience +16
Agnes van Sonderen, Roland D. Thijs, Elias C. Coenders et al. · Neurology · 2016 · 648 citations · Full text